MedPath

Severity Over Time of Early Forms of Spondyloarthritis

Not yet recruiting
Conditions
Spondyloarthritis
Spondyloarthritis, Axial
Registration Number
NCT06261931
Lead Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Brief Summary

Spondyloarthritis (SpA) is a group of chronic inflammatory pathologies whose progression over time is poorly defined, and in particular the clinical and instrumental elements that can predispose to a condition of disease severity are not completely known. It would be important to have an idea of what the predisposing factors are, possibly already at baseline, and possibly also at follow up, of severe disease, so as to be able to act early with more aggressive and targeted therapies on these patients, so as to achieve remission.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
387
Inclusion Criteria
  • age >18 years;
  • Diagnosis of SpA confirmed by the rheumatologist with duration of symptoms <
  • 2 years;
  • Signature of the written informed consent to the study
Exclusion Criteria
  • Age < 18 years;
  • Patients suffering from other rheumatic pathologies (even in overlap), or genetic diseases such as Marfan syndrome, Ehlers Danlos syndrome
  • Any medical or psychiatric condition that in the judgment of the investigator would prevent the participant from complying with the protocol or completing the study according to the protocol.
  • Refusal to sign the informed consent to the study.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
spondyloarthritis severityt0 baseline 3hours, t1 3 months 3hours,t2 6 months 3hours,t2 12months 3hours,every six months up to the tenth year

evaluation of disease severity at 10 years in the entire study population

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Fondazione Policlinico Universitario A. Gemelli IRCCS

🇮🇹

Roma, Italy

© Copyright 2025. All Rights Reserved by MedPath